Chalcone derivative, preparation method and application in medicine

Through the structural modification and compound design of Pseudomonas aeruginosa C, highly effective anti-tumor chalcone derivatives have been developed, which solves the problem of limited inhibitory effect of existing anti-tumor drugs on various tumor cells and achieves the goal of inhibiting multiple tumor cells. Significant inhibition of tumor cells and effective attack of drug-resistant cells.

CN105085220AActive Publication Date: 2015-11-25吴久鸿
3 Cites 3 Cited by

Patent Information

Application Number
CN201410206107.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2014-05-15
Publication Date
2015-11-25
Estimated Expiration
2034-05-15

AI Technical Summary

Technical Problem

Existing anti-tumor drugs have limited inhibitory effects on a variety of tumor cells and suffer from drug resistance problems, making it difficult to effectively target multiple types of cancer cells.

Method used

A series of chalcone derivatives were developed by structurally modifying Pseudomonas trichophylla C. These compounds were prepared using the Claisen-Schmidt condensation method and purified by reaction under alkaline conditions and high performance liquid chromatography to form compounds with New compounds with high antitumor activity.

Benefits of technology

These derivatives show significant anti-tumor activity and have potent inhibitory effects on a variety of tumor cells, including drug-resistant nasopharyngeal carcinoma cells. They also significantly increase the inhibition rate by inducing apoptosis mechanisms, providing new anti-tumor treatments. plan.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to a chalcone derivative, its preparation method and an application of the chalcone derivative in medicine, specifically to a chalcone derivative as shown in the general formula (I), its preparation method, a pharmaceutical composition containing the derivative and an application of the pharmaceutical composition used as a therapeutic agent, especially used as an antitumor agent. The definition of each substituent group in the general formula (I) is the same as a definition in the specification.
Need to check novelty before this filing date? Find Prior Art